Sucampo Pharmaceuticals, Inc. (SCMP) is a publicly traded company in the Unknown sector. Across all available filings, 31 corporate insiders have executed 453 transactions totaling $176.8M, demonstrating a bearish sentiment with -$175.8M in net insider flow. The most recent transaction on Feb 13, 2018 involved a transaction of 6,084 shares valued at $109.5K.
No significant insider buying has been recorded for SCMP in the recent period.
No significant insider selling has been recorded for SCMP in the recent period.
Based on recent SEC filings, insider sentiment for SCMP is bearish with an Insider Alignment Score of 0/100 and a net flow of -$175.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Sucampo Pharmaceuticals, Inc. (SCMP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 31 insiders are actively trading SCMP stock, having executed 453 transactions in the past 90 days. The most active insider is Ryuji Ueno (Executive), who has made 93 transactions totaling $155.4M.
Get notified when executives and directors at SCMP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 13, 2018 | Driggs Alex | Executive | Disposition | 6,084 | $18.00 | $109.5K | |
| Feb 13, 2018 | Patrick Meyenburg Jason | Executive | Disposition | 30,228 | $18.00 | $544.1K | Large |
| Feb 13, 2018 | W. Bryan Jones | Executive | Disposition | 5,139 | $18.00 | $92.5K | |
| Feb 13, 2018 | P. Pfreundschuh Peter | Executive | Disposition | 263 | $18.00 | $4.7K | |
| Feb 13, 2018 | Lichtlen Peter | Executive | Disposition | 24,000 | $18.00 | $432.0K | |
| Feb 13, 2018 | A. Kiener Peter | Executive | Disposition | 44,856 | $18.00 | $807.4K | Large |
| Feb 13, 2018 | Johnson John | Executive | Disposition | 5,130 | $18.00 | $92.3K | |
| Feb 13, 2018 | Greenleaf Peter | Executive | Disposition | 129,729 | $18.00 | $2.3M | Large |
| Feb 13, 2018 | Maxwell Donley Matthew | Executive | Award | 36,975 | $18.00 | $665.5K | Large |
| Feb 13, 2018 | R. Edick Paul | Executive | Disposition | 14,930 | $18.00 | $268.7K | |
| Feb 13, 2018 | J. Spiegel Robert | Executive | Disposition | 5,130 | $18.00 | $92.3K | |
| Feb 13, 2018 | P. Walbert Timothy | Executive | Disposition | 5,130 | $18.00 | $92.3K | |
| Feb 13, 2018 | Oconnell Maureen | Executive | Disposition | 5,130 | $18.00 | $92.3K | |
| Feb 13, 2018 | Ueno Ryuji | Executive | Tender | 5,406,585 | $18.00 | $97.3M | Large |
| Feb 13, 2018 | Kuno Sachiko | Executive | Tender | 5,137,344 | $18.00 | $92.5M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 2 | $189.8M | 49.8% |
Sale(S) | 266 | $176.3M | 46.3% |
Exercise(M) | 39 | $6.8M | 1.8% |
Disposition(D) | 12 | $5.0M | 1.3% |
Exercise (Options)(X) | 8 | $1.0M | 0.3% |
Payment(F) | 3 | $878.8K | 0.2% |
Award(A) | 81 | $871.3K | 0.2% |
Purchase(P) | 8 | $479.8K | 0.1% |
Gift(G) | 30 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Conversion(C) | 3 | $0 | 0.0% |
Insider selling pressure at Sucampo Pharmaceuticals, Inc. has increased, with 31 insiders executing 453 transactions across all time. Total sales of $176.3M significantly outpace purchases of $479.8K, resulting in a net outflow of $175.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.